Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Ananda positions itself for medicinal cannabis revolution

Jeremy Sturges-Smith explains plans for Nex-listed company
bottles
Cannabis oils have a number of beneficial properties

Ananda Developments Ltd (LON:ANA) has positioned itself for the legalisation of medicinal cannabis in the UK.

The Nex-listed group raised £930,000 at a price of just under a ha’penny (£.0045) and is now looking for investments in the medicinal cannabis space.

WATCH: Ananda Developments 'building strong relationships in the medicinal cannabis space'

“We see a lot of health benefits and are excited about all of the people we can help with medicinal cannabis,” Jeremey Struges-Smith, Head of Investor Relations, told Proactive.

He emphasises the focus will be on medicinal cannabis, not recreational.

And though the group has yet to make an investment, it is talking to companies and is ‘quite a long way down the line’ on due diligence.

One of these operates out of Britain and is developing a technology platform to make the use of medicinal cannabis easier in everyday life.

Ananda is also looking further afield, in Israel and The Netherlands, where the regimes are more tolerant and also in Canada, which is soon to complete the legalisation process.

The end goal would be to make either a few investments or take a bet on one company and reverse a private vehicle into Ananda, says Sturges-Smith.

“The aim is to outlast as the initial excitement around cannabis once the market is fully regulated and to establish a platform on which we as a team can build something really exciting.”

Gap in the market

Sturges-Smith’s personal opinion is that medicinal cannabis will be legal in the UK within six months.

“There is a huge amount of movement and even when we started this company six months ago we didn't think it would be progressing as fast as now.”

Ananda offers an opportunity for retail investors to get exposure as a lot of London brokers will not trade on Canadian stocks especially Canadian cannabis stocks.

“There is huge demand and we saw a gap in the market.”

View full ANA profile View Profile

Ananda Developments Timeline

Related Articles

Canntab pills
June 01 2018
The company is putting a pharmaceutical spin on the growing cannabis market
1519327525_WeedMD-photo-for-Proactive.jpg
February 22 2018
The company is developing its medical cannabis for both domestic and global markets

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use